People
Industrial Partners & Affiliates
We actively welcome industry partners and other non-academic stake holders to be affiliates of the Centre for Predictive in vitro Models. This enables us to keep affiliates informed of possible engagement and collaborative opportunities and to discuss ideas to shape our research activity. The following companies are already part of our industrial affiliates club.
Please register to join us
 Dr Haysam AhmedContract Researcher  TNO Innovations for Lifehaysam.ahmed@tno.nl liver-on-chip, disease model, 3D cell culture |
Mrs Eleanor D'AgostinoScientist Unilever R&D07792 484937 eleanor.dagostino@unilever.com Oral Care, Dentistry, Gingivitis, Periodontal disease |
Mr Roy EdwardSales Mktg Director BioStatus Limited01509381006 roy@biostatus.com Sample Preparation, Assay Development, Cell Tracking, Cell Viability, Cell Proliferation, Fluorescent Probes |
Dr Jason EkertSenior Director and Head of Complex In Vitro Models GlaxoSmithKline+1 856 278-3919 jason.x.ekert@gsk.com Disease models, Drug safety, PK/PD models |
Dr Nikolas GaioCTO and founder BIOND Solutions B.V.+31628313367 nikolas@biondteam.com Organ-on-Chip, company, Microfluidic, Complext 3D tissues, muscle, cancer |
 Mr Michael HelmeBusiness Development Emulate Incmike.helme@emulatebio.com Safety, Toxicology, Liver, Lung, Intestine, Kidney |
 Dr Antoni HomsCTO R&D and Innovation Cherry Biotech0767178907 antoni.homs@cherrybiotech.com Organ-on-Chip, Medical Devices, Animal Testing Alternatives, Theranostics, Microfluidics, Biosensors |
Dr Gail JenkinsR&D director Unilever, Beauty & Personal Care Divisiongail.jenkins@unilever.com Skin barrier, Skin ageing, Hair Biology, Axillary Biology |
Dr Michael JonesCEO Cell Guidance Systems01223967317 michael.jones@cellgs.com Protein stability and sustained release, Functionalized scaffolds and supports |
Mr Doug MajorBusiness Development Engineer LifeTech Festo07584 889698 douglas.major@festo.com Automation, Platform, Development, Time to Market |
Mrs Charlotte OhoninCEO & Founder NORGANOID+346805500909 c.ohonin@norganoid.at Organoid, Brain-On-Chip, Neurodegenerative Diseases, Disease Models, Personalized Medicine |
Dr. Marian Raschke Investigational Toxicology Bayer AG, Pharmaceutials Division, Reseach and Developmentmarian.raschke@bayer.com in vitro toxicity testing, advanced cellular models, organs-on-chips |
Dr Clive RoperDirector, In Vitro Toxicology In Vitro Toxicology Charles River Laboratories07736 344451 clive.roper@crl.com skin absorption, investigative toxicology, safety pharmacology, 3D toxicology |
Mr James SoperBusiness Development Manager (Ximbio) Cancer Research UKjames.soper@ximbio.com Oncolgy, Research tools from all research fields |
Dr Sandrine VessillierPrincipal Scientist National Institute of Biological Standards and Control (Nibsc)sandrine.vessillier@nibsc.org Immunotoxicology, Cytokine release assay, flowcytometry |
Dr Linda WainwrightSenior Biologist Beauty & Personal Care Unilever R&D01234248054 linda.wainwright@unilever.com skin, epidermis, barrier, senescence, itch, in vitro models |
Dr Paul WalkerHead of Toxicology Toxicology Cyprotex an Evotec Companyp.walker@cyprotex.com Tissue Organoids and Microtissues, Toxicology, Drug Induced Liver Injury, Mechanisms of Action (MOA), Transcriptomics, High Content Imaging |
Mr John WatsonBusiness Development Manager TTP Ventus TTP Ventus07724 828913 john.watson@ttpventus.com microfluidic pump, microfluidic flow control, microfluidic accuracy and precision, pulsation free microfluidic flow, microfluidic flow recirculation, compact and silent micropump |
Dr Donald WellingsManaging Director Spheritech07540 803320 don.wellings@spheritech.com regenerative medicine, 3D cell culture, Tissue repair, wound healing |
